Acadian Asset Management
UTMD icon

Acadian Asset Management’s Utah Medical Products UTMD Stock Holding History

Acadian Asset Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-453
Closed -$40K – 1871
2022
Q1 		$40K Buy
+453
New +$41.7K ﹤0.01% 1492
2018
Q1 		– Sell
-1,598
Closed -$130K – 1848
2017
Q4 		$130K Buy
+1,598
New +$125K ﹤0.01% 1039
2017
Q2 		– Sell
-2,791
Closed -$174K – 1597
2017
Q1 		$174K Sell
2,791
-1,594
-36% -$100K ﹤0.01% 1062
2016
Q4 		$319K Buy
4,385
+1,754
+67% +$114K ﹤0.01% 939
2016
Q3 		$157K Hold
2,631
– – ﹤0.01% 1000
2016
Q2 		$166K Hold
2,631
– – ﹤0.01% 963
2016
Q1 		$165K Hold
2,631
– – ﹤0.01% 953
2015
Q4 		$154K Hold
2,631
– – ﹤0.01% 1010
2015
Q3 		$142K Hold
2,631
– – ﹤0.01% 950
2015
Q2 		$157K Hold
2,631
– – ﹤0.01% 965
2015
Q1 		$157K Hold
2,631
– – ﹤0.01% 958
2014
Q4 		$158K Hold
2,631
– – ﹤0.01% 925
2014
Q3 		$128K Hold
2,631
– – ﹤0.01% 809
2014
Q2 		$135K Sell
2,631
-1,973
-43% -$101K ﹤0.01% 838
2014
Q1 		$267K Sell
4,604
-745
-14% -$40.7K ﹤0.01% 756
2013
Q4 		$306K Sell
5,349
-202
-4% -$11.1K ﹤0.01% 754
2013
Q3 		$329K Hold
5,551
– – ﹤0.01% 694
2013
Q2 		$302K Buy
+5,551
New +$261K ﹤0.01% 656

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Acadian Asset Management's UTMD Position: Q2 2022 in Review

Acadian Asset Management sold out of Utah Medical Products (UTMD) in Q2 2022, closing a stake of 453 shares — an estimated $40K sold.

Acadian Asset Management first reported a position in UTMD in Q2 2013 and held it in 18 quarters. The position peaked at $329K in Q3 2013. 75 funds tracked by Wall St. Rank hold UTMD as of Q2 2022.

  • Acadian Asset Management reported no remaining Utah Medical Products position as of Q2 2022 after selling out during the quarter.
  • Acadian Asset Management sold 453 Utah Medical Products shares in Q2 2022, an estimated $40K.
  • Acadian Asset Management first reported a position in Utah Medical Products in Q2 2013 and held it in 18 quarters.
  • Acadian Asset Management's Utah Medical Products position peaked at $329K in Q3 2013.
  • 75 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2022.

Based on Acadian Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.